Efficacy and safety of nilotinib in Japanese patients with imatinib-resistant or -intolerant Ph+ CML or relapsed/refractory Ph+ ALL: a 36-month analysis of a phase I and II study

Author： Usuki Kensuke  

Publisher： Springer Publishing Company

ISSN： 0925-5710

Source： International Journal of Hematology, Vol.95, Iss.4, 2012-04, pp. : 409-419

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

A phase I/II study of ofatumumab (GSK1841157) in Japanese and Korean patients with relapsed or refractory B-cell chronic lymphocytic leukemia

By Ogawa Yoshiaki   Ogura Michinori   Suzuki Tatsuya   Ando Kiyoshi   Uchida Toshiki   Shirasugi Yukari   Tobinai Kensei   Lee Je   Kase Masazumi   Katsura Koichi   Hotta Tomomitsu  

International Journal of Hematology, Vol. 98, Iss. 2, 2013-08 ,pp. : 164-170

Springer Publishing Company

Access to resources Recommend Favorite

Erratum to: A phase I/II study of ofatumumab (GSK1841157) in Japanese and Korean patients with relapsed or refractory B-cell chronic lymphocytic leukemia

By Ogawa Yoshiaki   Ogura Michinori   Suzuki Tatsuya   Ando Kiyoshi   Uchida Toshiki   Shirasugi Yukari   Tobinai Kensei   Lee Je   Kase Masazumi   Katsura Koichi   Hotta Tomomitsu  

International Journal of Hematology, Vol. 99, Iss. 3, 2014-03 ,pp. : 354-355

Springer Publishing Company

Access to resources Recommend Favorite

Monosomy 13 in metaphase spreads is a predictor of poor long-term outcome after bortezomib plus dexamethasone treatment for relapsed/refractory multiple myeloma

By Kiyota Miki  

International Journal of Hematology, Vol. 95, Iss. 5, 2012-05 ,pp. : 516-526

Springer Publishing Company

Access to resources Recommend Favorite

Results of a phase 2 study of valproic acid alone or in combination with all-trans retinoic acid in 75 patients with myelodysplastic syndrome and relapsed or refractory acute myeloid leukemia

By Kuendgen Andrea   Knipp Sabine   Fox Frank   Strupp Corinna   Hildebrandt Barbara   Steidl Christian   Germing Ulrich   Haas Rainer   Gattermann Norbert  

Annals of Hematology, Vol. 84, Iss. 1, 2005-12 ,pp. : 61-66

Springer Publishing Company

Access to resources Recommend Favorite

Phase II study of troxacitabine, a novel dioxolane nucleoside analog, in patients with untreated or imatinib mesylate-resistant chronic myelogenous leukemia in blastic phase

By Giles F.J.   Feldman E.J.   Roboz G.J.   Larson R.A.   Mamus S.W.   Cortes J.E.   Verstovsek S.   Faderl S.   Talpaz M.   Beran M.   Albitar M.   O'Brien S.M.   Kantarjian H.M.  

Leukemia Research, Vol. 27, Iss. 12, 2003-12 ,pp. : 1091-1096

Elsevier

Access to resources Recommend Favorite